百亞股份(003006.SZ):2023年外圍省份市場和電商渠道的大健康產品收入佔比約40%
格隆匯1月22日丨百亞股份(003006.SZ)披露投資者關係活動記錄表顯示,2023年外圍省份市場和電商渠道的大健康產品收入佔比約40%,且佔比逐季度環比提高。2024年公司仍將大健康系列作為重點,通過對品牌資源投放和渠道精細化運營,進一步提高產品品牌勢能,希望大健康產品能佔到衞生巾規模40%左右,外圍省份和電商渠道大健康佔比會更高些。公司將會對益生菌系列產品進行升級迭代,預計2024年上半年推出新品。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.